Adding the new calcium antagonist mibefradil to patients...

Adding the new calcium antagonist mibefradil to patients receiving long-term β-blocker therapy results in improved antianginal and antiischemic efficacy

Adam Schneeweiss, Isaac Kobrin, Vincent Charlon, Abraham Caspi, Alon Marmor, Samuel Sclarovsky, Leonardo Reisin, Zvi Zchlesinger
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
135
Year:
1998
Language:
english
DOI:
10.1016/s0002-8703(98)70093-6
File:
PDF, 139 KB
english, 1998
Conversion to is in progress
Conversion to is failed